StonvexLoading…
StonvexStonvexStonvexCore line items from ARHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.38B | $1.27B | $1.29B | $1.23B |
Operating Income | $88.89M | $87.00M | $164.31M | $184.67M |
Net Income | $67.26M | $68.55M | $125.24M | $136.63M |
EPS (Diluted) | $0.48 | $0.49 | $0.89 | $0.98 |
Total Assets | $1.39B | $1.21B | $1.11B | $937.08M |
Total Liabilities | $976.52M | $862.57M | $764.91M | $727.39M |
Cash & Equivalents | $253.36M | $197.51M | $223.10M | $145.18M |
Free Cash Flow OCF − CapEx | $58.98M | $39.74M | $75.24M | $21.80M |
Shares Outstanding | 141.41M | 140.69M | 140.10M | 139.61M |